Page last updated: 2024-09-02

ecteinascidin 743 and Vomiting

ecteinascidin 743 has been researched along with Vomiting in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arenare, L; Borgato, L; Cecere, SC; Della Pepa, C; Di Napoli, M; Ferrandina, G; Lepori, S; Lorusso, D; Mangili, G; Mosconi, AM; Pignata, S; Raspagliesi, F; Salutari, V; Salvino, A; Scambia, G; Sorio, R	1
Capri, G; Cresta, S; D'Incalci, M; De Braud, F; Feilchenfeldt, JW; Gallerani, E; Gianni, L; Ielmini, N; Jimeno, J; Locatelli, A; Noberasco, C; Perotti, A; Sessa, C; Viganò, L; Zucchetti, M	1
Dirix, LY; Jain, MM; Jiao, JJ; Manikhas, GM; Natarajan, J; Parekh, T; Park, K; Staddon, AP; Thertulien, R; Vermorken, JB; Zannikos, P	1
Colombo, N; del Campo, JM; Gómez, J; Gore, M; Kaye, S; Krasner, CN; McMeekin, S; Parekh, T; Park, YC; Sessa, C; Vermorken, JB; Zintl, P	1

Reviews

1 review(s) available for ecteinascidin 743 and Vomiting

Article	Year
Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials. Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Dioxoles; Disease-Free Survival; Drug Administration Schedule; Fatigue; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Ovarian Neoplasms; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Vomiting	2013

Article

Year

Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials.

Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Dioxoles; Disease-Free Survival; Drug Administration Schedule; Fatigue; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Ovarian Neoplasms; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Vomiting

2013

Trials

2 trial(s) available for ecteinascidin 743 and Vomiting

Article	Year
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer. European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:7 Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Breast Neoplasms; Dioxoles; Doxorubicin; Drug Administration Schedule; Female; Humans; Liver; Middle Aged; Nausea; Neutropenia; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Vomiting	2009
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Asthenia; Dioxoles; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Single-Blind Method; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Vomiting; Young Adult	2012

Article

Year

Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer.

European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:7

Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Breast Neoplasms; Dioxoles; Doxorubicin; Drug Administration Schedule; Female; Humans; Liver; Middle Aged; Nausea; Neutropenia; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Vomiting

2009

Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies.

Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2

Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Asthenia; Dioxoles; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Single-Blind Method; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Vomiting; Young Adult

2012

Other Studies

1 other study(ies) available for ecteinascidin 743 and Vomiting

Article	Year
Emesis and nausea related to single agent trabectedin in ovarian cancer patients: a sub-study of the MITO15 project. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:6 Topics: Adult; Antiemetics; Antineoplastic Agents; Cohort Studies; Dioxoles; Female; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Prospective Studies; Tetrahydroisoquinolines; Trabectedin; Vomiting	2017

Article

Year

Emesis and nausea related to single agent trabectedin in ovarian cancer patients: a sub-study of the MITO15 project.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:6

Topics: Adult; Antiemetics; Antineoplastic Agents; Cohort Studies; Dioxoles; Female; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Prospective Studies; Tetrahydroisoquinolines; Trabectedin; Vomiting

2017